Introduction

This webinar will discuss the FDA's current thinking on good practices for disseminating off-label information by firms for their FDA-approved or cleared products (drugs for both human and animals and medical devices for humans). This webinar will also discuss the FDA proposed and recommended practices for responding to both non-public and public unsolicited requests made through emerging electronic media (e.g., social media or other public electronic media). In addition, several public comments will be discussed in response to the FDA's recent guidance document.

Useful links

• Further event details More information about the event

Venue

Online Training

Online Training, 1000 N West Street, Suite 1200, Wilmington,DE, 400069, India

Useful links

• Venue information More information about the venue

Organised by

GlobalCompliancePanel

Contact information

Online Training
United States of America
800-447-9407
Contact us by email

---